CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)

Format

48T, 96T, 96T×5, 96T×10, 96T×100
Detection range

27.4-20,000pg/mL
Application

Chemiluminescent immunoassay for Antigen Detection.
Organism species

Homo sapiens (Human)
Sensitivity

The minimum detectable dose of this kit is typically less than 9.5pg/mL
Sample type

Serum, plasma and other biological fluids
Manual Links
Assay length

2h, 40min
Method

Double-antibody Sandwich
Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Alternative Names

IDGFL; ADGF; ADA2; Cat Eye Syndrome Critical Region Protein 1
Item Name

Cat Eye Syndrome Chromosome Region, Candidate 1
Research Area

Neuro science;
Properties

Felix vulgaris genes or proteins used as antigen, synthetic peptide.

Gene target

CLIA Kit for Cat Eye Syndrome Chromosome Region Candidate CECR1
Gene symbol

ADA2
Short name

CLIA Kit for Cat Eye Syndrome Chromosome Region, Candidate 1 (CECR1)
Species

Cat, Cats
Alternative name

CLIA reagent to measure catalase Eye Syndrome Chromosome Region, Candidate 1 (catalase eye syndrome chromosome region, candidate 1)
Alternative technique

kits
Alternative to gene target

cat eye syndrome chromosome region, candidate 1, CECR1 and IDBG-933 and ENSG00000093072 and 51816, proteoglycan binding, Extracellular, CECR1 and IDBG-641275 and ENSBTAG00000017313 and 617805
Tissue

eye, region
Disease

syndrome